Selbyville, DE -- (SBWIRE) -- 10/26/2018 -- U.S. neurostimulation devices market was dominating the industry due to rising prevalence of neurological disorders along with presence of geriatric patient pool. According to the American Neurological Association, stroke prevalence in the country is nearly 6.8 million and chronic low back pain affects nearly 32 million people. This leads to increase in demand for neurostimulators to treat such chronic disorders.

Rapid technological advancements along rising adoption of minimally invasive therapies will substantially influence neurostimulation devices market. Favorable reimbursement scenario for neurostimulators in developed countries is another factor accelerating industry growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467711/

Growing geriatric population suffering from neurological disorders will propel neurostimulation devices market growth over the coming years. Rising incidences of neurological disorders including Parkinson's disease, dementias, Alzheimer's disease, epilepsy and migraine should fuel demand for neurostimulation devices in the future. Neurostimulation devices market will exceed USD 16.0 billion by 2024; as per a new research report.

Neurostimulation devices market growth will be hindered by unavailability of skilled doctors and healthcare professionals to treat patient pool suffering from neurological diseases. Complications associated with neurostimulators is further anticipated to impede business growth.

Spinal cord stimulators held the largest revenue share in 2016 due to its increasing awareness and adoption by patients suffering from failed back surgery syndrome. Increasing focus of industry players to develop technologically advanced spinal cord stimulators will further stimulate its demand over the forecast period. Deep brain stimulators will witness considerable growth owing to increasing incidences of Parkinson's disease along with favorable reimbursement scenario in developed economies.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467711/

Germany will drive Europe neurostimulation devices market due to growing prevalence of neurological disorders coupled with increasing baby boomers in the country. Increasing annual mortality rate associated with neurological diseases will further fuel development of new products and increase demand for neurostimulators in the future.

Increasing burden of neurological disorders including dementia, epilepsy, Parkinson disease coupled with increasing R&D expenditure will drive China neurostimulation devices market growth. Surging elderly patient pool suffering from such disorders is another major factor propelling demand for neurostimulators in the country.

Major industry players operating in neurostimulation devices are Boston Scientific Corporation, Cyberonics, Abbott (St. Jude Medical) and Medtronic. New product launch and emphasis on acquisition, merger and partnerships are major growth strategies adopted by market players to strengthen their product portfolio.

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Neurostimulation devices industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Application trends

2.1.4. Regional trends

Chapter 3. Neurostimulation Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing demand for minimally invasive technologies in the developed countries

3.3.1.2. Rising prevalence of neurological disorders in U.S and Europe

3.3.1.3. Growing adoption of innovative and technologically advanced products

3.3.1.4. Increasing number of elderly patients with neurological disorders in the U.S and European countries

3.3.2. Industry pitfalls & challenges

3.3.2.1. Complications associated with neurostimulation devices

3.3.2.2. Lack of skilled healthcare practitioners

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By application

3.5. Pricing analysis

3.5.1. U.S

3.5.2. Europe

3.6. Regulatory landscape

3.6.1. U.S

3.6.2. Europe

3.7. Porter's analysis

3.8. Company market share analysis, 2016

3.8.1. Strategy dashboard

3.9. PESTEL analysis

More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

2018-2023 United States Implantable Neurostimulation Devices Market Report (Status and Outlook)

In 2017, the Implantable Neurostimulation Devices market size was xx million in United States, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023.

https://www.marketstudyreport.com/reports/2018-2023-united-states-implantable-neurostimulation-devices-market-report-status-and-outlook?utm_source=RR-SP

About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/